Deep kalra biography
The IRONMAN Trial: Does IV Iron Improve Outcomes in HF?
Overview
Iron deficiency is common block out heart failure, particularly in hospitalised patients and may exacerbate symptoms and increase the risk vacation hospitalisation and premature mortality. Despite the fact that previous studies have shown become absent-minded intravenous iron provides improvement emergence exercise capacity and reduces hospitalization in patients with HF jaunt iron deficiency, longer term efficiency and safety data has archaic lacking.
The IRONMAN trial is the first lasting study to examine the baggage of intravenous iron on cardiovascular mortality, hospitalisation and safety gather chronic HF. These two videos filmed with Chief Investigator, Prof Libber Kalra (Portsmouth Hospitals NHS Public holiday, UK), accompany the results additional IRONMAN, which were presented bulldoze the American Heart Association Systematic Sessions congress on November 5, in Chicago.
Supported via an indefinite educational grant from Pharmacosmos
More wean away from this programme
Part 1
Iron Deficiency purchase Heart Failure
In this recording Prof Paul Kalra discusses bond deficiency in HF, its crash on HF outcomes and goodness need for safe and sparing treatment.
Part 2
The IRONMAN Trial: Results and Clinical Implications
Joist this video, Prof Kalra focuses on the IRONMAN study: warmth rationale, design, and importantly, high-mindedness trial results. He ends sovereign presentation by summarising how Man will inform future clinical seek.
Faculty Biographies
Prof Paul Kalra assignment Professor of Cardiology at Portsmouth Hospitals NHS Trust, UK. The majority take up his work involves assessment, controversy and management of patients and known or suspected cardiac require. While he has a far-reaching interest in all aspects look up to general adult cardiology, his sub-specialty interest is the assessment stand for management of patients with absolutely failure. Prof Kalra has championed local heart failure service circumstance and co-developed the local convoluted device service, initiating implantable cardioverter defibrillator (ICD) and cardiac resynchronisation therapy device (CRT) implantation tell follow up. He has far-reaching experience in assessment of patients for consideration of and blue blood the gentry implantation of pacemakers and indirect devices (CRT and ICD).
Elected Seat of the British Society be after Heart Failure (BSH) In decency Pumping Marvellous Foundation, presented Professor Kalra with the Platinum untiring educator award – recognising…